DEALS
Zhong Lun Assists Orinko in Acquiring 70% Quotas in OMIKRON
Zhong Lun Assists Orinko in Acquiring 70% Quotas in OMIKRON
Recently, Orinko Advanced Plastics Co., Ltd (stock code: 688219.SH, “Orinko” or the "Acquirer") announced that it intends to enter into a quota purchase agreement with MICCA 22 S.R.L and INVESTAR S.R.L, through its indirect wholly-owned subsidiary Aldex Advanced Plastics (Hong Kong) Co., Limited, to respectively acquire 35% quotas in OMIKRON S.R.L (the "Target Company") held by each of MICCA 22 S.R.L and INVESTAR S.R.L for a consideration not exceeding EUR 10.35 million respectively. The acquisition price amounts to EUR 20.7 million plus corresponding interest. In addition, pursuant to the bonus clauses in such quota purchase agreement, the total acquisition price, after integrating such bonus, does not exceed EUR 25 million.
Orinko is one of the largest new materials enterprises with the widest customer coverage in China and its product business mainly includes modified new materials, special engineering materials, environmentally friendly high-performance PCR materials, and multifunctional membrane materials, forming an industrial cluster. These products are widely used in numerous national pillar industries and emerging industries such as automobiles, home appliances, new energy, consumer electronics, electrical and electronics, AI, medical, rail transit, home building materials, and security.
The Target Company is an Italian enterprise specializing in the production and application of modified materials. Its products mainly impart special properties to base materials (such as plastics and composites) through chemical or physical modification technologies to meet the specific needs of industrial customers.
Zhong Lun Law Firm, as legal counsel to the Acquirer, provided throughout the entire transaction comprehensive legal services, including coordinating legal due diligence, transaction structure design, drafting and negotiation of transaction documents, and assistance with signing. The mandate was managed by partner Vincent Chen with team members including associate Liheng Zhang.
